News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,007 Results
Type
Article (746)
Company Profile (5)
Press Release (17256)
Section
Business (5508)
Career Advice (6)
Deals (980)
Drug Delivery (2)
Drug Development (2601)
Employer Resources (1)
FDA (439)
Job Trends (430)
News (9347)
Policy (761)
Tag
Academia (51)
Allergies (5)
Alliances (1330)
ALS (3)
Alzheimer's disease (37)
Antibody-drug conjugate (ADC) (4)
Approvals (442)
Artificial intelligence (10)
Autoimmune disease (4)
Bankruptcy (6)
Best Places to Work (395)
BIOSECURE Act (1)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (1)
Breast cancer (11)
Cancer (78)
Cardiovascular disease (5)
Career advice (4)
CAR-T (3)
CDC (1)
Cell therapy (8)
Clinical research (2029)
Collaboration (32)
Compensation (2)
COVID-19 (172)
CRISPR (3)
C-suite (18)
Cystic fibrosis (9)
Data (109)
Depression (5)
Diabetes (15)
Diagnostics (285)
Digital health (1)
Drug discovery (5)
Drug pricing (38)
Drug shortages (1)
Earnings (2365)
Editorial (1)
Employer resources (1)
Events (2739)
Executive appointments (27)
FDA (500)
Frontotemporal dementia (1)
Funding (19)
Gene editing (3)
Generative AI (1)
Gene therapy (4)
GLP-1 (35)
Government (139)
Guidances (11)
Healthcare (544)
Immunology and inflammation (6)
Immuno-oncology (2)
Indications (1)
Infectious disease (175)
Inflammatory bowel disease (3)
Influenza (1)
Intellectual property (3)
Interviews (2)
IPO (468)
IRA (1)
Job creations (44)
Job search strategy (4)
Layoffs (8)
Legal (164)
Liver cancer (1)
Longevity (1)
Lung cancer (8)
Lymphoma (2)
Machine learning (3)
Manufacturing (18)
MASH (1)
Medical device (278)
Medtech (286)
Mergers & acquisitions (537)
Metabolic disorders (46)
Multiple sclerosis (12)
Neurodegenerative disease (5)
Neuropsychiatric disorders (2)
Neuroscience (68)
NextGen: Class of 2026 (244)
Non-profit (62)
Now hiring (3)
Obesity (27)
Opinion (3)
Ovarian cancer (5)
Pain (6)
Pancreatic cancer (7)
Parkinson's disease (3)
Partnered (3)
Patents (8)
Patient recruitment (2)
Peanut (1)
People (1603)
Pharmaceutical (4)
Pharmacy benefit managers (19)
Phase 1 (638)
Phase 2 (1082)
Phase 3 (667)
Pipeline (129)
Policy (12)
Postmarket research (34)
Preclinical (318)
Prostate cancer (2)
Psychedelics (1)
Radiopharmaceuticals (4)
Rare diseases (20)
Real estate (79)
Recruiting (1)
Regulatory (566)
Reports (1)
Research institute (54)
Resumes & cover letters (1)
RSV (1)
Series A (5)
Series B (2)
Special edition (1)
Spinal muscular atrophy (16)
Startups (114)
Stomach cancer (1)
Supply chain (5)
Tariffs (7)
The Weekly (2)
Vaccines (31)
Venture capital (1)
Weight loss (21)
Women's health (2)
Date
Last 7 days (10)
Last 30 days (41)
Last 365 days (567)
2026 (74)
2025 (577)
2024 (868)
2023 (1046)
2022 (1435)
2021 (1737)
2020 (1617)
2019 (1330)
2018 (1073)
2017 (838)
2016 (777)
2015 (870)
2014 (644)
2013 (524)
2012 (538)
2011 (629)
2010 (508)
Location
Africa (17)
Alabama (2)
Alaska (1)
Arizona (20)
Asia (1185)
Australia (71)
California (283)
Canada (102)
China (10)
Colorado (19)
Connecticut (8)
Delaware (6)
Europe (1744)
Florida (21)
Georgia (4)
Idaho (2)
Illinois (16)
India (3)
Indiana (41)
Japan (16)
Kansas (5)
Maine (1)
Maryland (9)
Massachusetts (126)
Michigan (5)
Minnesota (8)
Missouri (4)
Nebraska (1)
Nevada (1)
New Hampshire (1)
New Jersey (49)
New Mexico (1)
New York (87)
North Carolina (15)
Northern California (134)
Ohio (11)
Oklahoma (1)
Oregon (1)
Pennsylvania (27)
Rhode Island (1)
South America (47)
South Carolina (1)
Southern California (109)
Tennessee (5)
Texas (49)
United States (830)
Utah (21)
Virginia (9)
Washington D.C. (2)
Washington State (9)
Wisconsin (5)
18,007 Results for "civica rx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Civica To Launch Long-Acting Insulin Glargine in the US in January 2026
October 16, 2025
·
3 min read
Press Releases
MedImpact Completes Acquisition of Sav-Rx
February 3, 2026
·
2 min read
Press Releases
Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options
October 16, 2025
·
9 min read
Press Releases
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
January 29, 2026
·
5 min read
Press Releases
BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)
January 12, 2026
·
6 min read
Business
Bouwien Smits Joins Civica Rx as Site Vice President and General Manager of New Virginia Manufacturing Facility
Civica Inc. is proud to announce that pharmaceutical industry leader Bouwien Smits has joined Civica as the new Site Vice President and General Manager of the company’s new sterile injectable manufacturing facility.
November 1, 2023
·
2 min read
BioCapital
Jay Benson Joins Civica Rx as Chief Manufacturing and Supply Chain Officer
Civica Inc. announced that biopharma industry veteran Jay Benson has joined Civica as Chief Manufacturing and Supply Chain Officer.
June 13, 2023
·
3 min read
Press Releases
Wellgistics Health Enters into LOI to Acquire Kare Rx Hub
November 4, 2025
·
1 min read
Press Releases
RIS Rx Appoints John Driscoll as Chairman of the Board
October 16, 2025
·
2 min read
BioCapital
California Selects Civica Rx as Its Insulin Manufacturing Partner
Civica Inc. announced it will manufacture insulins for the State of California’s CalRx Biosimilar Insulin Initiative as part of its insulin manufacturing work.
March 18, 2023
·
5 min read
1 of 1,801
Next
